SEC Comment Letter 0000000000-24-011703 to LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

LIFECORE BIOMEDICAL, INC. \DE\
Date: Oct. 18, 2024 · CIK: 0001005286 · Accession: 0000000000-24-011703

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-282583

Date

October 18, 2024

Author

Paul Josephs

Form

UPLOAD

Company

LIFECORE BIOMEDICAL, INC. \DE\

Letter

October 18, 2024 Paul Josephs Chief Executive Officer Lifecore Biomedical, Inc. 3515 Lyman Boulevard Chaska, Minnesota 55318 Re:Lifecore Biomedical, Inc. Registration Statement on Form S-1 Filed October 10, 2024 File No. 333-282583 Dear Paul Josephs: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Eranga Dias at 202-551-8107 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing

Show Raw Text

October 18, 2024
Paul Josephs
Chief Executive Officer
Lifecore Biomedical, Inc.
3515 Lyman Boulevard
Chaska, Minnesota 55318
Re:Lifecore Biomedical, Inc.
Registration Statement on Form S-1
Filed October 10, 2024
File No. 333-282583
Dear Paul Josephs:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Eranga Dias at 202-551-8107 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing

SecProbe.io